A - Agilent Technologies Inc Stock Analysis
Agilent Technologies Inc (A) is a publicly traded company listed on the NYSE. It operates in the Diagnostics & Research industry, part of the broader Healthcare sector. The company has a market capitalization of 39.59B, generates annual revenue of 6.95B, and reports net income of 1.30B. As of the latest data, the stock is trading at 139.64 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The dividend yield (0.74%) is modest, often associated with growth-oriented companies. The stock exhibits higher volatility than the market, which may indicate greater risk and potential reward.
Analyst recommendation stands at Hold (3.89), indicating current market sentiment. Institutional ownership is reported at 91.20%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -1.82%, trading within a 52-week range of 96.43 - 160.27.
A - Agilent Technologies Inc
139.64
Analyst Consensus
Hold 3.89
A – Analyst Rating Summary
- Strong Buy: 6
- Buy: 13
- Hold: 9
- Sell: 0
- Strong Sell: 0
- Total Analysts: 28
| Index: | S&P 500 | P/E: | 30.56 | EPS (ttm): | 4.57 | Insider Own: | 0.48% | Shs Outstand: | 283.05M | Perf Week: | -5.98% |
| Market Cap: | 39.59B | Forward P/E: | 21.36 | EPS next Y: | 6.54 | Insider Trans: | -1.66% | Shs Float: | 282.13M | Perf Month: | 0.32% |
| Income(ttm): | 1.30B | PEG: | 2.35 | EPS next Q: | 1.37 | Inst Own: | 91.20% | Short Float: | 1.36% | Perf Quarter: | -1.03% |
| Revenue(ttm): | 6.95B | P/S: | 5.70 | EPS this Y: | 6.20% | Inst Trans: | -0.00% | Short Ratio: | 2.01 | Perf Half Y: | 22.50% |
| Book/sh: | 23.82 | P/B: | 5.86 | EPS next Y: | 10.10% | ROA: | 10.55% | Short Interest: | 3.85M | Perf Year: | -1.82% |
| Cash/sh: | 6.31 | P/C: | 22.13 | EPS next 5Y: | 9.10% | ROE: | 20.62% | 52W Range: | 96.43 - 160.27 | Perf YTD: | 2.62% |
| Dividend Est.: | 1.03 (0.74%) | P/FCF: | 34.36 | EPS past 3/5Y: | 3.03% 14.68% | ROIC: | 13.11% | 52W High: | 160.27 -12.87% | Beta: | 1.30 |
| Dividend TTM: | 1.00 (0.72%) | Quick Ratio: | 1.52 | Sales past 3/5Y: | 0.48% 5.41% | Gross Margin: | 52.50% | 52W Low: | 96.43 44.81% | Perf 5Y: | 8.97% |
| Dividend Ex-Date: | Jan 06, 2026 | Current Ratio: | 1.96 | EPS Y/Y TTM: | 3.34% | Oper. Margin: | 22.60% | RSI (14): | 42.30 | Volatility: | 2.86% 2.10% |
| Employees: | 18100 | Debt/Eq: | 0.53 | Sales Y/Y TTM: | 6.73% | Profit Margin: | 18.75% | Recom: | 1.77 | Target Price: | 169.50 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.47 | EPS Q/Q: | 24.96% | Payout: | 21.70% | Rel Volume: | 1.35 | Prev Close: | 144.83 |
| Sales Surprise: | 0.36% | EPS Surprise: | 0.36% | Sales Q/Q: | 9.41% | Earnings: | Nov 24 AMC | Avg Volume: | 1.92M | Price: | 139.64 |
| SMA20: | -1.48% | SMA50: | -3.46% | SMA200: | 10.47% | Undervalued: 21.38% | Volume: | 2,582,340 | Change: | -3.58% | |
Graham Classic formula value: 109.57
(P/E=8 * 1g) Min value: 70.17
(current P/E * 2g) Max value: 200.1
Average value: 126.61
About Agilent Technologies Inc
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The Life Sciences and Diagnostics Markets segment offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Applied Markets segment refers to the application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products. The Agilent CrossLab segment spans the entire lab with its extensive services and consumables portfolio in addition to software and laboratory automation solutions. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.